Zetta Genomics appoints director to lead strategic partnerships  

Andy Etheridge joins Zetta Genomics alongside a new Head of Product, tasked to power customer-focused solution development.

Zetta Genomics has appointed Andy Etheridge as its Director of Strategic Partnerships.  Liam White has also been brought in as Head of Product, to develop the company’s XetaBase platform in line with the growing data management needs of the genomics and precision medicine market. Together, the two appointments will accelerate Zetta’s strategic partnerships and growth plans. 

Ludo Chapman, Chair of Zetta Genomics, commented: “Andy’s deep experience in the healthtech space means he is uniquely placed to shift Zetta’s growth strategy into high gear. His deep understanding of customer needs and market trajectory will be pivotal as we roll out our XetaBase platform and transform the delivery of precision medicine for millions of people around the world.”

Andy Etheridge, CCO at Zetta Genomics, commented on his appointment: “Zetta Genomics has introduced a step change to precision medicine by enabling researchers and clinicians to drive greater insights by accumulating genomic data in a highly scalable database rather than in separate files. A prime motivation is to join at precisely the moment that Zetta grows at pace and scale – and to have the opportunity to shape my own team. I’m genuinely excited by this unique opportunity to bring my experience in healthcare technology to a start-up that is only just beginning to realise its world changing potential.”

Andy  was previously Marketing Services Director at IQVIA, a global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. With over 30 years’ experience in the healthtech space, and deep understanding of customer challenges and opportunities, Andy  is well placed to lead Zetta Genomics in its next phase of growth.

Head of Product strengthens commercial capabilities 

Liam White also joins Zetta Genomics as Head of Product. His team will work closely with  commercial colleagues to develop the company’s pioneering Xetabase platform – informed by the needs and ambitions of its growing global user base. Liam is highly experienced in the genomic technology space, having previously worked in product teams at Congenica and Prenetics. His appointment follows numerous technical hires across the Zetta Genomics team in recent months, in roles including software development, R&D and product commercialisation.

Prioritising strategic partnerships

Since its inception at the University of Cambridge, and within the ground-breaking 100,000 Genomes Project, Zetta Genomics has built strong customer and partner networks which include Microsoft, Fujitsu, Genomics England and the NHS Genomic Medicine Service. 

A key priority for Andy and Liam will be to lead a strategic partnership initiative at Zetta Genomics. The initiative will focus on identifying, recruiting and collaborating with partners who offer technologies that complement XetaBase. It will also explore partnerships that offer exciting XetaBase integration options for end users. XetaBase is already compatible with the Microsoft Azure and AWS cloud computing platforms. 

The ultimate ambition for Zetta is to scale the availability of precision medicine to patients through the reach of partner organisations – bringing faster and more agile genomic data management to both the clinic and lab. The ultimate promise of precision medicine is quicker diagnoses, more tailored treatment plans and increasingly accurate prognoses – particularly in the fields of oncology and rare disease.

Read more about Zetta’s full leadership team here.